MAPT and Alzheimer disease: This study sought to clarify the relationship between Aβ accumulation and CSF clearance prior to preclinical AD by comparing the gBOLD–CSF coupling—an increasingly reported indicator of the glymphatic system, which is thought to be the primary mechanism for clearing toxic wastes in the brain such as Aβ and tau—between fast-converters and slow-converters.